Single-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.
British PrecisionLife Ltd inks partnership with Metrodora Institute
Latest NewsBritish PrecisionLife Ltd and the Metrodora Institute have announced to launch clinical trials to improve the diagnosis and therapy of long COVID-related ME/CFS.
ERS Genomics with new CEO
AppointmentsDublin-based ERS Genomics Ltd appointed John E Milad as CEO in the middle of May. He took over from Erik Rhodes, CEO for the last eight years.
Transform Your Clonal Selection with Quantitative Fluorescent Screening
ProductsInnovate in Bio-Production – Discover how Fermentalg® is revolutionizing the natural food ingredient industry using the power of microalgae.
First dog snack from microbial protein
Latest NewsGerman-Portuguese biotech start-up MicroHarvest GmbH and a Munich-based pet food manufacturer want to launch the first dog snack made by single cell protein.
AC Immune and Takeda ink US$2.1bn biobucks deal
Latest NewsAC Immune and Takeda have inked an exclusive option license agreement for ACI-24.060, a first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression.
Sphere Fluidics appoints Chief Executive Officer
AppointmentsDale Levitzke has been appointed as CEO of Sphere Fluidics. He follows CEO and co-founder Dr Frank F. Craig, who announced his retirement after 14 years leading the company.
Memo Therapeutics AG increases Series C financing to CHF45m
Latest NewsSwiss antibody specialist Memo Therapeutics AG has added CHF20m to its Series C financing, bringing the total amount raised in the funding round to CHF 45 million.
Full house at European Cluster Conference
Latest NewsMore than 900 experts from clusters and the EU Commission discussed at the sold-out 9th European Cluster Conference what cluster policy is needed to make Europe a world leader in prioritised technology fields such as the green and digital transitions and biotechnology.
Danish 21st.BIO A/S opens multipurpose production plant
Latest NewsDanish CDMO 21st.BIO A/S has unveiled a new pilot plant facility to accelerate scaling of biotech processes ranging from food and beverages, agriculture, biomaterials, and biopharma.
Single-Use Simplicity under control
ProductsSingle-use bioreactor technology offers a set of benefits compared to common glass or stainless-steel vessels, including reduced downtime between runs, minimal cleaning effort, or decreased cross-contamination risk. In that regard, BioBLU® Single-Use Bioreactors combine the benefits of single-use bioreactor technology with the reliable performance of conventional glass or stainless-steel bioreactors. Furthermore, using them together with a powerful bioprocess controller like the BioFlo® 320 enables precise cell culture parameter control and seamless process transition to up to 40 L of working volume.